Clarivate Epidemiology’s coverage of atopic dermatitis (AD) comprises epidemiological estimates of key patient populations in 45 countries worldwide. We report the prevalence of AD for each…
Clarivate Epidemiology’s coverage of atopic dermatitis (AD) comprises epidemiological estimates of key patient populations in 45 countries worldwide. We report the prevalence of AD for each…
Clarivate Epidemiology’s coverage of atopic dermatitis (AD) comprises epidemiological estimates of key patient populations in 45 countries worldwide. We report the prevalence of AD for each…
Clarivate Epidemiology’s coverage of atopic dermatitis (AD) comprises epidemiological estimates of key patient populations in 45 countries worldwide. We report the prevalence of AD for each…
The coronavirus disease 2019 (COVID-19) Epidemiology Forecaster is a fully customizable SEIR(susceptible, exposed, infectious, recovered) model that allows users to develop scenario-based global…
The treatment of axial spondyloarthritis has been transformed in the last decade by the approval of biologics to treat the disease and the recognition that patients without evidence of radiographic…
Once limited to ankylosing spondylitis (AS), the axial spondyloarthritis (AxSpA) therapy market is undergoing rapid change as the definition of the disease expands beyond those with detectable…
MARKET OUTLOOK Sepsis is a life-threatening organ dysfunction resulting from a dysregulated host response to infection. It is one of the leading causes of death among developed countries, with…
The treatment of axial spondyloarthritis has been transformed in the last decade by the approval of biologics to treat the disease and the recognition that patients without evidence of radiographic…
By definition, rare diseases affect relatively few individual patients, but as a group they encompass up to 8,000 recognized rare diseases affecting approximately 10% of the U.S. population. The…